CCL2 and invasive ductal breast carcinoma: Through analysis of patient derived breast tissues and mouse models of DCIS, we showed that expression of CCL2, CCR2, phospho-SMAD3 and phospho-p42/44MAPK proteins were associated with invasive breast ductal carcinomas.